280 results on '"Park, Man Seong"'
Search Results
2. The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
3. Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
4. Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea
5. Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
6. Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
7. Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity
8. Laboratory information management system for COVID-19 non-clinical efficacy trial data
9. Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19
10. Age-Stratified Seroprevalence of Respiratory Syncytial Virus: Analysis using Prefusion F and G Protein Antibodies
11. Development and Validation of an Enzyme-Linked Immunosorbent Assay-Based Protocol for Evaluation of Respiratory Syncytial Virus Vaccines.
12. Immune Cells Are Differentially Affected by SARS-CoV-2 Viral Loads in K18-hACE2 Mice
13. Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant
14. A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
15. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome
16. 464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
17. 288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination
18. Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2
19. Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing
20. Genome-informed investigation of the molecular evolution and genetic reassortment of severe fever with thrombocytopenia syndrome virus
21. Prevention of hypoglycemia-induced neuronal death by minocycline
22. Animal models for the risk assessment of viral pandemic potential
23. Exploring the Genetic Diversity and Molecular Evolution of Seoul and Hantaan Orthohantaviruses.
24. Phylodynamics and Molecular Mutations of the Hemagglutinin Affecting Global Transmission and Host Adaptation of H5Nx Viruses
25. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
26. A Systems Vaccinology Approach Reveals the Mechanisms of Immunogenic Responses to Hantavax Vaccination in Humans
27. Low Neutralizing Activities to the Omicron Subvariants BN.1 and XBB.1.5 of Sera From the Individuals Vaccinated With a BA.4/5-Containing Bivalent mRNA Vaccine
28. Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies
29. 305. Clinical scoring system to predict viable viral shedding in patients with COVID-19
30. Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice
31. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
32. Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19
33. Serological Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and IgM Positivity Were Identified in Healthy Residents in Vietnam
34. Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model
35. Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition
36. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
37. SARS-CoV-2 emergence very likely resulted from at least two zoonotic events
38. Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient
39. Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing
40. Engineered Viral Vaccine Constructs with Dual Specificity: Avian Influenza and Newcastle Disease
41. Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies.
42. Risk of coronavirus disease 2019 transmission in an emergency department with multiple open beds
43. Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies
44. MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
45. Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
46. Seroepidemiologic survey of emerging vector-borne infections in South Korean forest/field workers
47. The Immune Correlates of Orthohantavirus Vaccine
48. Antiviral Efficacy of Pralatrexate against SARS-CoV-2
49. Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins
50. TRIM28 functions as a negative regulator of aggresome formation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.